Clinical Trials on Colonic Neoplasms in Finland
Total 2990 results
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
Tampere University HospitalRecruitingPostoperative Pain | Nausea and Vomiting, Postoperative | Chronic Pain Post-ProceduraalFinland
-
Tampere University HospitalCompletedProstate Neoplasms | Toxicity Due to RadiotherapyFinland
-
University of HelsinkiBayerCompleted
-
Chinese University of Hong KongChangi General Hospital; University Hospital AugsburgRecruitingColorectal Neoplasms | Colorectal Cancer | AdenomaHong Kong
-
Kuopio University HospitalUnknownProstate CancerFinland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Turku University HospitalUnknownMammary Ductal CarcinomaFinland
-
Tampere University HospitalUniversity of Helsinki; Tampere UniversityActive, not recruitingOvarian CancerFinland
-
Finnish Breast Cancer GroupCompleted
-
Boneca CorporationCompletedHead and Neck CancerFinland
-
Turku University HospitalUnknown
-
PfizerCompletedKidney Cancer | Kidney Neoplasms | Renal Cell Carcinoma | Renal Cancer | Renal Cell Cancer | Cancer of the Kidney | Cancer of KidneyFinland
-
Turku University HospitalUniversity of TurkuCompleted
-
Tampere University HospitalVaralan urheiluopistoUnknown
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
PfizerTerminatedSarcoma | Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Colorectal NeoplasmsUnited States, Finland, Canada, Germany
-
Turku University HospitalUnknown
-
Finnish Breast Cancer GroupSanofi; Hoffmann-La Roche; AstraZenecaCompleted
-
Tampere University HospitalOlfactomics OyRecruiting
-
Joint Authority for Päijät-Häme Social and Health...Tampere University; University of JyvaskylaActive, not recruitingCarcinoma, Basal Cell | Neoplasms, Basal Cell | Photosensitizing Agents | PhotochemotherapyFinland
-
Helsinki University Central HospitalRecruitingChronic Disease | Medication Adherence | Medication NonadherenceFinland
-
Boneca CorporationTerminated
-
Heikki JoensuuLund University; University of Lausanne HospitalsCompleted
-
Turku University HospitalRecruitingHypoxia | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CarcinomaFinland
-
Turku University HospitalActive, not recruitingLocalized Prostate CancerFinland
-
Turku University HospitalRecruitingIBS - Irritable Bowel Syndrome | Microbial SubstitutionFinland
-
Turku University HospitalRecruitingAdenomyosis | Uterine FibroidsFinland
-
Turku University HospitalRecruiting
-
Heikki JoensuuScandinavian Sarcoma GroupActive, not recruiting
-
Helsinki University Central HospitalActive, not recruiting
-
Tampere University HospitalTurku University Hospital; Oulu University HospitalTerminated
-
Orion Corporation, Orion PharmaCompleted
-
Turku University HospitalActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerFinland
-
University of HelsinkiHelsinki University Central HospitalRecruiting
-
Tampere University HospitalTampere UniversityNot yet recruitingProstate Cancer Recurrence After Radical ProstatectomyFinland
-
Turku University HospitalCompletedSquamous Cell Carcinoma of the Head and NeckFinland
-
Turku University HospitalRecruitingHead and Neck Squamous Cell CarcinomaFinland
-
Helsinki University Central HospitalActive, not recruiting
-
Helsinki University Central HospitalActive, not recruitingPancreatic Neoplasms | Pancreatic FistulaFinland
-
Helsinki University Central HospitalUniversity of HelsinkiUnknownEnd Stage Renal Disease | Kidney Transplantation | Reperfusion Injury | Delayed Graft FunctionFinland
-
University of JyvaskylaHelsinki University Central HospitalCompleted
-
Helsinki University Central HospitalUniversity of HelsinkiRecruiting
-
Tampere UniversityLund University; University of Helsinki; Hospital District of Helsinki and Uusimaa and other collaboratorsEnrolling by invitation
-
Helsinki University Central HospitalActive, not recruitingProstate CancerFinland
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Tampere University HospitalHelsinki University Central Hospital; Tampere University; University of Eastern... and other collaboratorsActive, not recruiting